1. Home
  2. Buyout

Category: Pharma and Healthcare

Private equity majors circle $9bn-valued Parexel as Pamplona Capital mulls exit options – report

Private equity giant EQT is up against a consortium of three other buyout majors interested in buying Pamplona Capital's $9bn-valued pharma business Parexel, it has emerged. The post Private equity majors circle $9bn-valued Parexel as

ArchiMed buys Stragen Pharma

ArchiMed has acquired a majority stake in Switzerland-based Stragen Pharma, a company that produces generic drugs for complex and life-threatening illnesses.

Pharmaron reopens RMB-linked CB market

Pharmaron Beijing Co brought the first renminbi-linked but dollar settled convertible bond to the market in nearly five years this week, raising $600m from the dual tranche deal. Bankers called it a ‘smashing success’ and

KKR Forms Geode Health to Increase Access to Mental Health Care

New Platform to Provide Quality-Centric Outpatient Mental Health Services NEW YORK--(BUSINESS WIRE)-- KKR today announced the creation of Geode Health (“Geode” or the “Company”), a mental health services company that will partner with leading psychiatrists,

Podiatry Growth Partners Announces Partnerships with Step Lively Foot…

Expands Columbus presence to 12+ locations, doctors(PRWeb June 24, 2021)Read the full story at https://www.prweb.com/releases/podiatry_growth_partners_announces_partnerships_with_step_lively_foot_and_ankle_centers_feet_first_podiatry/prweb18026414.htm

Healthcare valuations heat up as high-profile assets crystallise competition

Reinvigorated by the massive boost in financing and attention received with the spread of the pandemic, the healthcare sector saw entry multiples pick up in Q1 2021 to hit a record high of 13.7x. Alessia

Clearlake’s Unifrax Inks Big Public Add-On

Unifrax, a portfolio company of Clearlake Capital, has agreed to acquire publicly traded Lydall at an enterprise value of approximately $1.3 billion. Clearlake acquired Unifrax from American Securities in October 2018. Lydall (NYSE: LDL) designs

GI Partners Closes Fund VI

Middle-market investor GI Partners has held an oversubscribed and above target closing of GI Partners Fund VI LP with $3.9 billion in total commitments. The firm’s earlier fund closed at its hard cap in November

Palladium Creates Position, Hires Business Development Director

Palladium Equity has added Meahgan O’Grady to its team as Director of Business Development, a newly-created position. Through her past work experience, Ms. O’Grady brings to Palladium numerous relationships across multiple channels, including development teams

Waterland to acquire Norwegian company Bano

Dutch PE firm Waterland is to acquire Norwegian company Bano, a provider of bathroom products for the healthcare sector. 

Palatine buys majority stake in KCP-backed Routes Healthcare

Palatine Private Equity has acquired a majority stake in homecare health service provider Routes Healthcare from Key Capital Partners (KCP).

EverArc to Buy SK Capital’s Fire-Fighting Products Maker

EverArc Holdings, a publicly-listed acquisition company, has agreed to acquire Perimeter Solutions, a portfolio company of SK Capital, in a transaction valued at approximately $2 billion. Perimeter was formed by SK Capital in March 2018

Olympus Pet Food Platform Expand to Colorado

3D Corporate Solutions, a portfolio company of Olympus Partners, has acquired All American Pet Proteins (AAPP). Olympus acquired 3D Corporate in May 2019. 3D Corporate develops, processes, distributes, and sells a variety of pet food

Varsity Closes Fifth Probo Add-On

Probo Medical, a portfolio company of Varsity Healthcare Partners since October 2018, has acquired IMAX Medical. IMAX specializes in the sale, purchase, inspection, installation/de-installation, and transport of pre-owned medical diagnostic imaging equipment including ultrasound, X-Ray,

Goldman Takes Minority Stake in Arlington Capital

Goldman Sachs Asset Management (GSAM) has made a non-voting minority equity investment in Arlington Capital Partners. Arlington Capital was founded in 1999 and has completed over 90 acquisitions since its inception. Sectors of interest include

Brand Investor Prelude Growth Hits Hard Cap

Prelude Growth Partners, an investor in consumer brands, has closed Prelude Growth Partners II LP at its hard cap of $250 million. The firm’s second fund was oversubscribed and was raised in just four months.

Ardian invests in lab testing business GBA Group

The German provider of laboratory services to the food, environment and pharmaceutical sectors, also serves the growing European medical cannabis industry

After 37 Years, Yellow Wood Reunites Dr. Scholl’s

Scholl’s Wellness Company, a portfolio company of Yellow Wood Partners, has agreed to acquire the Scholl footcare brand (Scholl), which operates globally outside of the Americas, from consumer-goods company Reckitt Benckiser. The buy of Scholl

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.